Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III IVIG in recurrent abortion with immune etiology
2014-005419-18Phase 3Completed
- Sponsor
- silvia sanchez ramon
- Start
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in recurrent miscarriage (RPL) comparing IVIG with Placebo (2 arms). Primary endpoint: Number of live births. Started Apr 2016; status: completed.
02
Drugs
immune globulin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2014-005419-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005419-18.